SCHEMBL7733047

SCHEMBL7733047

CC(=O)Nc1nc2ccc(C(=O)CBr)cc2s1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 12/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
PIK3CG P48736 2/20 0.68
PIK3CA P42336 1/20 0.68
PIK3CB P42338 1/20 0.68
PI4KB Q9UBF8 1/20 0.68
NPC1 O15118 3/20 0.66
RAB9A P51151 3/20 0.66
STAT1 P42224 1/20 0.66
CYP1A2 P05177 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2C19 P33261 2/20 0.65
CYP2C9 P11712 1/20 0.65
GSK3B P49841 1/20 0.62
FSCN1 Q16658 1/20 0.61
PDPK1 O15530 1/20 0.61
LCK P06239 1/20 0.60
HTT P42858 1/20 0.59
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30561486 0.85 DYRK1A (0.79) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL19807983 0.85 DYRK1A (0.79) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL6058154 0.83 DYRK1A (0.77) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL18472973 0.82 SMN1; SMN2 (1.00) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL19807985 0.80 SMN1; SMN2 (0.69) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL6057541 0.80 NPC1 (1.00) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL715950 0.79 DYRK1A (1.00) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL7734175 0.79 DYRK1A (0.67) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL10170616 0.77 DYRK1A (1.00) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB
SCHEMBL2175580 0.77 DYRK1A (1.00) DYRK1ASMN1; SMN2PIK3CGPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3487498-B1 HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND APPLICATION THEREOF ZHANG XIAOHU (CN) 2023-09-06 EP disclosed
WO-2018017435-A1 HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND APPLICATION THEREOF ACCRO BIOSCIENCE INC. (KY) 2018-01-25 WO disclosed
US-6407122-B1 NEUROPROTECTIVE AGENTS, ANTIISCHEMIC, AND HYPERGLYCEMIC AGENTS; HUNTINGTON*S, PARKINSON*S, AND ALZHEIMER*S DISEASE;AMYOTROPHIC LATERAL SCLEROSIS TREATMENT; NERVOUS SYSTEM AND BRAIN DISORDERS PHARMACIA & UPJOHN S.P.A. (IT) 2002-06-18 US disclosed
EP-1037890-A1 AMINO-BENZOTHIAZOLE DERIVATIVES PHARMACIA & UPJOHN S.p.A. (IT) 2000-09-27 EP disclosed
WO-1999028318-A1 AMINO-BENZOTHIAZOLE DERIVATIVES PHARMACIA & UPJOHN S.P.A. (IT) 1999-06-10 WO disclosed